6.
Unger J, Parkin C
. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance. Postgrad Med. 2011; 123(4):81-91.
DOI: 10.3810/pgm.2011.07.2307.
View
7.
Saik O, Klimontov V
. Hypoglycemia, Vascular Disease and Cognitive Dysfunction in Diabetes: Insights from Text Mining-Based Reconstruction and Bioinformatics Analysis of the Gene Networks. Int J Mol Sci. 2021; 22(22).
PMC: 8620086.
DOI: 10.3390/ijms222212419.
View
8.
Feinkohl I, Aung P, Keller M, Robertson C, Morling J, McLachlan S
. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care. 2013; 37(2):507-15.
DOI: 10.2337/dc13-1384.
View
9.
Cheng K, Wang H, Tseng K, Wang Y, Chang C, Chen Y
. Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats. Front Pharmacol. 2022; 12:771271.
PMC: 8804339.
DOI: 10.3389/fphar.2021.771271.
View
10.
Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R
. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012; 61(11):2993-7.
PMC: 3478543.
DOI: 10.2337/db12-0224.
View
11.
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P
. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2008; 360(2):129-39.
DOI: 10.1056/NEJMoa0808431.
View
12.
Piarulli F, Sartore G, Sechi A, Basso D, Fogar P, Greco E
. Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects. Oxid Med Cell Longev. 2017; 2017:9185272.
PMC: 5684594.
DOI: 10.1155/2017/9185272.
View
13.
Nair S, Sobotka K, Joshi P, Gressens P, Fleiss B, Thornton C
. Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia. 2019; 67(6):1047-1061.
DOI: 10.1002/glia.23587.
View
14.
. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S83-S96.
DOI: 10.2337/dc22-S006.
View
15.
McVicar C, Hamilton R, Colhoun L, Gardiner T, Brines M, Cerami A
. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes. 2011; 60(11):2995-3005.
PMC: 3198080.
DOI: 10.2337/db11-0026.
View
16.
Choi H, Kim N, Kim B, Seo M, Heo J
. TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells. Int J Mol Sci. 2018; 19(11).
PMC: 6274800.
DOI: 10.3390/ijms19113428.
View
17.
Bonds D, Miller M, Bergenstal R, Buse J, Byington R, Cutler J
. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010; 340:b4909.
PMC: 2803744.
DOI: 10.1136/bmj.b4909.
View
18.
Yin L, Kharbanda S, Kufe D
. MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation. Int J Oncol. 2009; 34(6):1691-9.
PMC: 3027209.
DOI: 10.3892/ijo_00000300.
View
19.
Martinez-Ortega A, Munoz-Gomez C, Gros-Herguido N, Remon-Ruiz P, Acosta-Delgado D, Losada-Vinau F
. Description of a Cohort of Type 1 Diabetes Patients: Analysis of Comorbidities, Prevalence of Complications and Risk of Hypoglycemia. J Clin Med. 2022; 11(4).
PMC: 8875497.
DOI: 10.3390/jcm11041039.
View
20.
Murakami Y, Ishikawa K, Nakao S, Sonoda K
. Innate immune response in retinal homeostasis and inflammatory disorders. Prog Retin Eye Res. 2019; 74:100778.
DOI: 10.1016/j.preteyeres.2019.100778.
View